Etripamil for patients with atrial fibrillation with rapid ventricular rate (AFib-RVR) Phase 3 pivotal trial ... Important factors that could cause actual results to differ materially from those ...

PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)- Commercial capabilities ...

PDUFA date of March 27, 2025 for CARDAMYST (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT) - Commercial capabilities build out in process, with proposed launch in PSVT targe ...

Phase 3 pivotal trial in AFib-RVR expected to begin enrollment in H1 ... Important factors that could cause actual results to differ materially from those in the forward-looking statements include ...

Phase 3 pivotal trial in AFib-RVR expected to begin enrollment in H1 2025 ... Important factors that could cause actual results to differ materially from those in the forward-looking statements ...

BACKGROUND: Hypertensive disorders of pregnancy (HDP) are a major cause of maternal morbidity and mortality and are associated with acute cardiac events in the peripartum period, as well as ...

If left untreated, Afib can lead to stroke, heart failure and premature cardiac death. But fortunately, Afib is treatable and, in some cases, preventable.

A rapid heartbeat and shortness of breath could be signs of atrial fibrillation (AFib), an irregular heartbeat. Dr. Jim Stone, a cardiac electrophysiologist at North Medical Center in Tupelo, helps ...

Proper body care, learning about specific triggers, and taking a more holistic approach to heart health can help you manage your condition. Atrial fibrillation (AFib) is the most common form of ...